Mind the gap: closing the growing chasm between academia and industry
. Nevertheless, if it were possible to generate more aligned science between academia and industry, as well as management teams who are experienced to navigate the intricate maze, it may be possible to also benefit investors as well.
Students and early career professionals without any exposure to the industry may not understand the major differences between programs and how they are rooted in different disciplines, and therefore end up on a course that does not align with their career goals.
If professionals are unwilling to return to academia, it would be wise for students to gain hands-on experience via industrial internships in the early stages of the educational process and to open collaborations later in their careers. One notable example is Northeastern University in Boston, where the new Roux Institute integrates research, venture and entrepreneurship.
This curriculum can only be created with input from the entire ecosystem. This may mean that courses are taught with modules from different faculties and that basic introduction courses must be developed. Facilities are already available within many establishments; thus, this is a logistical issue rather than a resource one, lowering the bar for change.
This would continue to bring new first-in-class assets into the pipeline, create potential future niche pharma players and move drug development away from ‘me too’ development and the dominance of a handful of companies. This could also allow for new drugs to be developed in much-needed areas, such as neglected tropical diseases and other infectious diseases. In this way, it would propel a new wave of pipeline drugs, biotech and entrepreneurs.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts - Nature BiotechnologyAn engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts
Lire la suite »
Nature Biotechnology - Protein structure predictionThe November issue is live On our cover, Chowdhury et al. present a deep learning method to predict a protein’s structure from its sequence alone, with applications to orphan and de novo–designed proteins
Lire la suite »
Spatial genomics maps the structure, nature and evolution of cancer clones - NatureA workflow centred around base-specific in situ sequencing generates detailed maps of, and can phenotypically characterize, the unique set of subclones of cancers.
Lire la suite »
A biotechnology company announces the world’s first regulatory approval for a donor derived microbiome drug productBiomeBank announces the world’s first drug approval for a chronic infection called Clostridioides difficile.
Lire la suite »
Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity - Nature BiotechnologyEvolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity
Lire la suite »
Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing - Nature BiotechnologyRe-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing - PKU1898
Lire la suite »